Oxford BioTherapeutics' Debt - II Round

Oxford BioTherapeutics raised a round of funding on January 26, 2017. Investors include Oxford Finance.

Oxford BioTherapeutics is an international, clinical-stage biotechnology company focused on developing antibody-based therapies to treat cancer. Combining immuno-oncology, antibody-drug conjugates, an…

Articles about Oxford BioTherapeutics' Debt - II Round: